A number of studies have suggested overexpression of PSAT1 protein as a poor prognostic marker in colorectal cancer [17], esophageal squamous cell carcinoma [15], NSCLC [14] and ER(−) breast cancer [16]. This evidence concerns the gene ESR1 and breast cancer.